Navigation Links
Investigational agent targets gene signaling pathways to improve response for patients with CLL
Date:12/8/2012

standard chemo-immunotherapy and eventually become resistant. For these harder-to-treat patients, ibrutinib in combination with rituximab appears to be a safer option with high efficacy and without the related risks," said Jan Burger, MD, PhD, lead author and Associate Professor of Medicine in the Department of Leukemia at The University of Texas MD Anderson Cancer Center in Houston. "Based on these promising results, we need larger-scale studies of ibrutinib-rituximab in high-risk CLL, with the goal of accelerating the development of this therapy for patients who most urgently need better options."

Dr. Burger will present this study in an oral presentation on Sunday, December 9, at 4:30 p.m. EST at the Georgia World Congress Center in Thomas Murphy Ballroom 4, Level 5, Building B.


'/>"/>
Contact: Andrea Slesinski
aslesinski@hematology.org
614-352-5096
American Society of Hematology
Source:Eurekalert

Page: 1 2 3 4 5 6

Related medicine news :

1. Updated Clinical Results Show Experimental Agent Ibrutinib as Highly Active in CLL Patients
2. Rilpivirine for HIV: Added benefit for single agent proven
3. Travel Services (MyTSOnline) in Valencia Teams Up With Vendors to Become the Number One Travel Agent in the Santa Clarita Valley
4. Mayo Clinic gets FDA approval for new imaging agent for recurrent prostate cancer
5. Scientists ID Cancer-Causing Agent in Smokeless Tobacco
6. Therapy combining exercise and neuroprotective agent shows promise for stroke victims
7. New substances 15,000 times more effective in destroying chemical warfare agents
8. Difficult to diagnose cases of infectious endocarditis solved with SPECT/CT imaging agent
9. Imaging agents predict breast cancer response to endocrine therapy
10. Pig stomach mucins are effective as anti-viral agents for consumer products
11. Method developed by VTT targets diagnosis of early Alzheimers disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... 29, 2014 As a chiropractic physician ... understands that there’s a direct connection between the condition ... and back. "Since conventional shoe inserts and orthotics weren’t ... of my own," he said. , Customizable to a ... support for the foot in order to help prevent ...
(Date:8/29/2014)... (HealthDay News) -- Researchers have discovered that people with ... Dyslexia -- the most commonly diagnosed learning disorder in ... writing. Previous research showed that brain activity is ... studies focused only on a small number of brain ... analyze how multiple brain regions use networks to communicate ...
(Date:8/29/2014)... August 29, 2014 Empty Nest ... at http://www.blogtalkradio.com/dr-carol-francis/2014/08/29/psychologist-dr-carol-francis-addressing-empty-nest-syndrome .     , Mothers and fathers, ... money, marital bliss, prodding, laughing and sweating through ... house this week. Relief and parenting pride ... what.” Dr. Carol Francis as a ...
(Date:8/29/2014)... "I have had many hospital stays, including ... many other surgeries in my lifetime, as I am a ... stays, I was unable to move freely in order to ... freely had to physically rotate me every 30 minutes to ... and pulled the sheets. This was jarring and caused me ...
(Date:8/29/2014)... (PRWEB) August 29, 2014 Scientists from ... idea that progression-free survival correlates with overall survival of ... the new research. Click here to read it ... The Netherlands studied the cases of 523 mesothelioma ... studies. , “PFSR-18 [progression-free survival at 18 weeks ...
Breaking Medicine News(10 mins):Health News:Scientists Find Differences in Brains of Those With Dyslexia 2Health News:Psychologist Dr. Carol Francis Addressing Empty-Nest Syndrome on Talk Radio Today 2Health News:Psychologist Dr. Carol Francis Addressing Empty-Nest Syndrome on Talk Radio Today 3Health News:InventHelp® Client Develops Equipment for Surgical and Bedridden Patients (HCD-279) 2Health News:European Study Says Disease Progression Predicts Mesothelioma Survival Better Than Treatment Response, According to Surviving Mesothelioma 2
... (HealthDay News) -- New genetic mapping of children with ... gene mutation are particularly well-skilled in the use of ... specific variation of the so-called "PCSK6 gene" and hand-motor ... to suggest that there could be an association between ...
... Japanese research group led by Prof. Ryusuke Kakigi and ... and Prof. Masami K Yamaguchi (Chuo University) found that ... temporal sulcus (STS) when processing positive (happy) and negative ... reported in NeuroImage . Near infrared spectroscopy ...
... , THURSDAY, Nov. 4 (HealthDay News) -- During ... clothes to keep infants warm can lead to dangerous ... syndrome (SIDS), U.S. experts warn. Infants are sensitive ... their body temperature. Research has shown that multiple layers ...
... children, especially those with eczema, are unnecessarily avoiding ... according to researchers at National Jewish Health. The ... children, and is often based primarily on data ... factors, including patient and family history, physical examination, ...
... Cambridge hope to revolutionise cancer therapy after discovering one of ... system to treat cancerous tumours have failed. New ... that a type of stromal cell found in many cancers ... role in suppressing the immune response in cancerous tumours ...
... could help smuggle drugs into the gut, according to ... Journal of Nanotechnology . There are several drugs ... could be targeted at absorption by the lower intestine. ... colon cancer for instance, medication delivered by mouth must ...
Cached Medicine News:Health News:Research Suggests Link Between 'Handedness' and Dyslexia 2Health News:Infants' hemodynamic responses to happy and angry facial expressions 2Health News:Overheating in Infants Can Lead to SIDS, Experts Warn 2Health News:Food-allergy fears drive overly restrictive diets 2Health News:Food-allergy fears drive overly restrictive diets 3Health News:Breakthrough in cancer vaccine research 2Health News:Colonic navigation 2
(Date:8/28/2014)... Aug. 28, 2014 Levi & Korsinsky announces ... the United States District Court for the District of ... who purchased Galectin Therapeutics Inc. ("Galectin" or the "Company") ... 28, 2014. For more information, click here: ... during the Class Period the Company violated federal securities ...
(Date:8/28/2014)...   Edison Nation Medical , the premier ... for product ideas to improve the health and ... through the 6-month search ( www.EdisonNationMedical.com/Seniors ) will ... healthcare retailers with whom Edison Nation Medical has ... 65 and older. The objective of ...
(Date:8/28/2014)... CAMBRIDGE, Mass. , Aug. 28, 2014 /PRNewswire/ ... treatments for diseases related to the human microbiome, ... Seres, Executive Vice President of R&D and Chief ... Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). ... implications of SER-109, a novel mixture of bacterial ...
Breaking Medicine Technology:SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of Class Action Against Galectin Therapeutics Inc. and Its Board of Directors and a Lead Plaintiff Deadline of September 29, 2014 -- GALT 2Edison Nation Medical Launches Open Innovation Search to Uncover Innovative Senior Care Products 2Edison Nation Medical Launches Open Innovation Search to Uncover Innovative Senior Care Products 3Seres Health to Present Clinical Findings at ICAAC 2014 Conference 2
... Anthera Pharmaceuticals,announced today they have reached agreement ... on a Phase 3 protocol for varespladib ... FDA,s Special Protocol Assessment,procedure. At the same ... European Medicines Agency (EMEA) on Anthera,s European ...
... Summary: Genmab has Completed Recruitment of Patients in the ... of Ofatumumab in Rituximab Refractory Follicular NHL, COPENHAGEN, ... has completed recruitment of patients in the,pivotal Phase III ... (NHL). Eighty-one patients,receiving treatment at the 1000 mg dose ...
Cached Medicine Technology:Anthera Completes Special Protocol Assessment With FDA and Receives EMEA Scientific Advice on Development Path Toward Varespladib Approval 2Anthera Completes Special Protocol Assessment With FDA and Receives EMEA Scientific Advice on Development Path Toward Varespladib Approval 3Recruitment Completed in Ofatumumab NHL Pivotal Study 2Recruitment Completed in Ofatumumab NHL Pivotal Study 3
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: